EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Next-generation CAR-macrophage therapies: Design principles and advances in cancer treatment

Weihua Wang, Songyue Guo, Qihui Chu, Qian Yu, Mariano Romero, Xiaoya Shi, Shuo Shan, Chao Gao, Shunli Fu, He Ren

Cancer Letters · 2026-12 · 662 · 218899

DOI: 10.1016/j.canlet.2026.218899 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Letters, 2026-12. Verfasst von Weihua Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Tumor Immunology and Cytotherapy of Medical Research Center, Shandong Provincial Key Laboratory of Clinical Research for Pancreatic Diseases, the Aff…. Hauptthemen laut MEDLINE: Neoplasms, Receptors, Chimeric Antigen, Macrophages, Immunotherapy, Adoptive. Die Arbeit nennt 214 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrophages possess intrinsic tumor-homing and tissue-infiltrating abilities, performing various effector functions, including phagocytosis and antigen presentation. These properties make chimeric antigen receptor macrophages (CAR-M) a promising approach to overcoming major barriers in cellular therapy for solid tumors. This review systematically compares and critically evaluates key design variables that determine the therapeutic activity and clinical feasibility of CAR-M, including CAR architecture, macrophage source, gene-delivery method, and manufacturing strategy. We also discuss emerging engineering approaches tailored to macrophage biology, including macrophage-adapted intracellular signaling, regulation of phagocytic checkpoints, metabolic and phenotypic reprogramming, and combinations with immunomodulatory therapies. Their therapeutic potential and translational boundaries are assessed based on current preclinical evidence and early clinical findings. Notably, the major barriers to clinical translation are shifting from focusing solely on antitumor potency to addressing system-level challenges involving cell source and product consistency, in vivo expansion and persistence, phenotypic stability, off-target toxicity, and scalable manufacturing. Therefore, we propose that next-generation CAR-M development should move beyond conventional optimization of the CAR construct to multidimensional engineering centered on macrophage biology. Coordinated optimization of receptor signaling, antigen recognition, cell-state control, delivery, and safety mechanisms will be essential to balance efficacy, persistence, safety, and manufacturability. This review provides an integrated framework for the rational design and clinical evaluation of CAR-M and the development of next-generation CAR-M cellular therapy platforms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsReceptors, Chimeric AntigenMacrophagesImmunotherapy, AdoptiveHumansAnimals

Stichwörter der Autor:innen

CAR-MClinical trialsDesign principlesImmunotherapySolid tumors

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Tumor Immunology and Cytotherapy of Medical Research Center, Shandong Provincial Key Laboratory of Clinical Research for Pancreatic Diseases, the Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 2…
  • Department of Pharmacy, Women and Children's Hospital, Qingdao University, Qingdao, 266000, China.
  • Centro NanoMat & Área Física, Departamento de Experimentación y Teoría de la Estructura de la Materia y sus Aplicaciones - DETEMA, Facultad de Química, Universidad de la República, Montevideo, Uruguay.

Zitieren

APA

Wang, W., Guo, S., Chu, Q., Yu, Q., Romero, M., Shi, X., Shan, S., Gao, C., Fu, S., & Ren, H. (2026). Next-generation CAR-macrophage therapies: Design principles and advances in cancer treatment. Cancer Letters, 662, 218899. https://doi.org/10.1016/j.canlet.2026.218899

Vancouver

Wang W, Guo S, Chu Q, Yu Q, Romero M, Shi X, et al. Next-generation CAR-macrophage therapies: Design principles and advances in cancer treatment. Cancer Letters. 2026;662:218899. doi:10.1016/j.canlet.2026.218899

BibTeX
@article{Wang2026,
  author = {Wang, Weihua and Guo, Songyue and Chu, Qihui and Yu, Qian and Romero, Mariano and Shi, Xiaoya and Shan, Shuo and Gao, Chao and Fu, Shunli and Ren, He},
  title = {Next-generation CAR-macrophage therapies: Design principles and advances in cancer treatment},
  journal = {Cancer Letters},
  year = {2026},
  volume = {662},
  pages = {218899},
  doi = {10.1016/j.canlet.2026.218899}
}
Kostenlos starten →